NCT00006082View on ClinicalTrials.gov

Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

August 31, 2002

Conditions
Lung Cancer
Interventions
DRUG

rubitecan

Trial Locations (1)

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00006082 - Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter